These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16885354)

  • 1. A novel functional polymorphism in the transforming growth factor-beta2 gene promoter and tumor progression in breast cancer.
    Beisner J; Buck MB; Fritz P; Dippon J; Schwab M; Brauch H; Zugmaier G; Pfizenmaier K; Knabbe C
    Cancer Res; 2006 Aug; 66(15):7554-61. PubMed ID: 16885354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors.
    Heegaard AM; Xie Z; Young MF; Nielsen KL
    J Cell Biochem; 2004 Oct; 93(3):463-75. PubMed ID: 15372625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells.
    Benckert C; Jonas S; Cramer T; Von Marschall Z; Schäfer G; Peters M; Wagner K; Radke C; Wiedenmann B; Neuhaus P; Höcker M; Rosewicz S
    Cancer Res; 2003 Mar; 63(5):1083-92. PubMed ID: 12615726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells.
    Kim ES; Sohn YW; Moon A
    Cancer Lett; 2007 Jul; 252(1):147-56. PubMed ID: 17258390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tamoxifen on transcriptional level of transforming growth factor beta (TGF-beta) isoforms 1 and 2 in tumor tissue during primary treatment of patients with breast cancer.
    Brandt S; Kopp A; Grage B; Knabbe C
    Anticancer Res; 2003; 23(1A):223-9. PubMed ID: 12680217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
    Kaklamani VG; Baddi L; Liu J; Rosman D; Phukan S; Bradley C; Hegarty C; McDaniel B; Rademaker A; Oddoux C; Ostrer H; Michel LS; Huang H; Chen Y; Ahsan H; Offit K; Pasche B
    Cancer Res; 2005 Apr; 65(8):3454-61. PubMed ID: 15833881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
    Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ
    J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta signaling in breast cancer.
    Buck MB; Knabbe C
    Ann N Y Acad Sci; 2006 Nov; 1089():119-26. PubMed ID: 17261761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: a possible dual role at different cancer stages.
    Shin A; Shu XO; Cai Q; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1567-70. PubMed ID: 15941974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
    Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
    J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An association between the matrix metalloproteinase 1 promoter gene polymorphism and lymphnode metastasis in breast cancer.
    Przybylowska K; Zielinska J; Zadrozny M; Krawczyk T; Kulig A; Wozniak P; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
    J Exp Clin Cancer Res; 2004 Mar; 23(1):121-5. PubMed ID: 15149160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA5 activation of the progesterone receptor gene promoter in breast cancer cells is influenced by the +331G/A polymorphism.
    Huggins GS; Wong JY; Hankinson SE; De Vivo I
    Cancer Res; 2006 Feb; 66(3):1384-90. PubMed ID: 16452193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of a polymorphism in the promoter region of the IL-12/23p40 gene.
    Shimokawa N; Nishiyama C; Hirota T; Tamari M; Hara M; Ikeda S; Okumura K; Ogawa H
    Clin Exp Allergy; 2009 Feb; 39(2):228-35. PubMed ID: 19134014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow stroma influences transforming growth factor-beta production in breast cancer cells to regulate c-myc activation of the preprotachykinin-I gene in breast cancer cells.
    Oh HS; Moharita A; Potian JG; Whitehead IP; Livingston JC; Castro TA; Patel PS; Rameshwar P
    Cancer Res; 2004 Sep; 64(17):6327-36. PubMed ID: 15342422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Sp1 transcription factor binds to the G-allele of the -1087 IL-10 gene polymorphism and enhances transcriptional activation.
    Larsson L; Johansson P; Jansson A; Donati M; Rymo L; Berglundh T
    Genes Immun; 2009 Apr; 10(3):280-4. PubMed ID: 18843277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells.
    Jungert K; Buck A; von Wichert G; Adler G; König A; Buchholz M; Gress TM; Ellenrieder V
    Cancer Res; 2007 Feb; 67(4):1563-70. PubMed ID: 17308095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
    Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
    Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel polymorphism in the promoter region of ERBB4 is associated with breast and colorectal cancer risk.
    Rokavec M; Justenhoven C; Schroth W; Istrate MA; Haas S; Fischer HP; Vollmert C; Illig T; Hamann U; Ko YD; Glavac D; Brauch H
    Clin Cancer Res; 2007 Dec; 13(24):7506-14. PubMed ID: 18094435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
    Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression.
    Mauro L; Catalano S; Bossi G; Pellegrino M; Barone I; Morales S; Giordano C; Bartella V; Casaburi I; Andò S
    Cancer Res; 2007 Apr; 67(7):3412-21. PubMed ID: 17409452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.